Wisconsin Alumni Research Foundation News
Our News Releases & Announcements
Expanding its strategic relationship with WARF, Cellectar Biosciences executes new license agreement
3.8.17 | Cellectar Biosciences
Cellectar Biosciences has entered into a licensing agreement with WARF for intellectual property rights covering the method of use for the company's lead compound in multiple myeloma.
WARF In the News
3.20.17 | UW–Madison News | Terry Devitt
Borrowing from nature is an age-old theme in science. Form and function go hand-in-hand in the natural world and the structures created by plants and animals are only rarely improved on by humans.